LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
At close: Apr 28, 2026, 4:00 PM EDT
9.45
+0.16 (1.72%)
After-hours: Apr 28, 2026, 7:04 PM EDT
LENZ Therapeutics Revenue
In the year 2025, LENZ Therapeutics had annual revenue of $19.09M. LENZ Therapeutics had revenue of $1.59M in the quarter ending December 31, 2025.
Revenue (ttm)
$19.09M
Revenue Growth
n/a
P/S Ratio
15.26
Revenue / Employee
$125,579
Employees
152
Market Cap
291.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.09M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.00M | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 79.59M |
| Compugen | 72.76M |
| Editas Medicine | 40.52M |
| C4 Therapeutics | 35.95M |
| Zentalis Pharmaceuticals | 26.87M |
| Abeona Therapeutics | 5.82M |
| AC Immune | 4.51M |
LENZ News
- 8 days ago - LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom - GlobeNewsWire
- 5 weeks ago - LENZ Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026 - GlobeNewsWire
- 7 weeks ago - LENZ Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia - GlobeNewsWire
- 2 months ago - LENZ Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire